Naxitamab Biosimilar

REQUEST MORE INFO
Catalogue No: abx831506
Price: US$391.50
(Size: 1 mg)

Orders to United States ship from United States

Naxitamab Biosimilar

Click on the image to see the image legend

Available Options

* Size:



Add to Cart Buy It Now GET A QUOTE

Documents

Datasheet SDS
Naxitamab is a monoclonal antibody biosimilar expressed in CHO cells, targeting Ganglioside GD2, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications.

Naxitamab is a chimeric monoclonal antibody targeting the GD2 antigen. GD2 antigen is expressed on the surface of tumors generated by neuroectoderm, including neuroblastoma, melanoma and osteosarcoma. By binding to the GD2 antigen on the tumor surface, naxitamab can trigger antibody-mediated cytotoxicity and activate the complement system in the immune system to achieve the effect of killing tumors.

Target Ganglioside GD2
Research Area Chimeric Monoclonal Antibodies, Biosimilars
Clonality Monoclonal
Reactivity Human
Expression Recombinant
Tested Applications ELISA
Host Human, Mouse
Recommended dilutions Optimal dilutions/concentrations should be determined by the end user.
Conjugation Unconjugated
Isotype IgG1 Kappa
Form Liquid
Purity > 95%
Purification Purified from cell culture supernatants by Protein A/G chromatography.
Storage Store at 4°C for up to 2 weeks. Aliquot and store at -20°C for long term storage. Avoid repeated freeze/thaw cycles.
Shelf Life 12 months.
Buffer 0.01 M PBS, pH 7.4.
CAS Number 1879925-92-4
Concentration 3.82 mg/ml
Availability Shipped within 5-10 working days.
Note THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.
Research Articles on Ganglioside GD2


Write a review

Tags:
(Click to show)